Concepedia

Mark A. Collins

MA

Statistics

Publications

16

Citations

696

H-Index

14

Active since

1987

Affiliations

Research Triangle Park Foundation(Current)

GlaxoSmithKline (United States)

Mark A. Collins is an author at Research Triangle Park Foundation specializing in medicinal chemistry, pharmacology, and life sciences.

Publications per year

1987–2014

16

Publications

16

Synthesis and Structure−Activity Relationship of Novel 6-Aryl-1,4- dihydrobenzo[<i>d</i>][1,3]oxazine-2-thiones as Progesterone Receptor Modulators Leading to the Potent and Selective Nonsteroidal Progesterone Receptor Agonist Tanaproget

Andrew Fensome, Reinhold H. W. Bender, Rajiv Chopra et al. · Journal of Medicinal Chemistry · 2005 · 91 citations · Full text

, , +17

Assay Development Guidelines for Image-Based High Content Screening, High Content Analysis and High Content Imaging

William Buchser, Mark A. Collins, Tina Garyantes et al. · 2014 · 87 citations

, , +11

New progesterone receptor antagonists: 3,3-disubstituted-5-aryloxindoles

Andrew Fensome, Reinhold H. W. Bender, Jeffrey Cohen et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 74 citations · Full text

, , +11

Inhibition of Plasminogen Activator Inhibitor-1 Activity by Two Diketopiperazines, XR330 and XR334 Produced by Streptomyces sp.

Justin S. Bryans, Peter Charlton, Inês Chicarelli-Robinson et al. · The Journal of Antibiotics · 1996 · 62 citations · Full text

, , +4

Novel pyrrole-containing progesterone receptor modulators

Mark A. Collins, Valerie Hudak, Reinhold H. W. Bender et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 52 citations · Full text

, , +12

1–5 of 16